An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).

Clinical trial NCT06634849 · RECRUITING

Trial details

NCT number: NCT06634849
Sponsor: Pathios Therapeutics Pty Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-11-04
Primary completion: 2027-04-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.